E. Azucena González-Navarro was not included as an author in the published article. The correct author contributions statement appears below:
Statements
Author contributions
MJ, DB-R, JM, OC, AMC and AMLM designed the study. PP and AG procured the tumor specimens for the cell lines, and CdT and NS characterized molecularly the samples. SP and ACM established the cell lines and tumor lysate. RC, GF-G, EA G-N and DB-R prepared the vaccines. MM, OC, VSM, and AMLM obtained clinical and laboratory data. RC, GF-G, EA G-N and DB-R analyzed immunologic data. MJ, DB-R, OC, JM, ACM and AMLM prepared the original manuscript. All authors provided manuscript review and approval.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
immunotherapy, dendritic, cell, vaccination, diffuse intrinsic pontine glioma
Citation
Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen A, González-Navarro EA, Paco S, Carcaboso AM, Santa-Maria Lopez V, Cruz O, de Torres C, Salvador N, Juan M, Mora J and Morales La Madrid A (2018) Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. Front. Oncol. 8:201. doi: 10.3389/fonc.2018.00201
Received
03 May 2018
Accepted
18 May 2018
Published
05 June 2018
Approved by
Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland
Volume
8 - 2018
Updates
Copyright
© 2018 Benitez-Ribas, Cabezón, Flórez-Grau, Molero, Puerta, Guillen, González-Navarro, Paco, Carcaboso, Santa-Maria Lopez, Cruz, de Torres, Salvador, Juan, Mora and Morales La Madrid.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Manel Juan, mjuan@clinic.cat; Andres Morales La Madrid, amorales@hsjdbcn.org
Specialty section: This article was submitted to Pediatric Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.